Shefali Miller et al.
Journal of clinical psychopharmacology, 32(6), 814-819 (2012-11-08)
To assess longer-term ziprasidone effectiveness in obese and non-obese patients with bipolar disorder (BD). Outpatients assessed with the Systematic Treatment Enhancement Program for BD Affective Disorders Evaluation and monitored with the Systematic Treatment Enhancement Program for BD Clinical Monitoring Form